Accord Healthcare, Inc.: Drug Recall
Recall #D-0392-2023 · 02/07/2023
Class II: Risk
Recall Details
- Recall Number
- D-0392-2023
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Accord Healthcare, Inc.
- Status
- Terminated
- Date Initiated
- 02/07/2023
- Location
- Durham, NC, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2,731,365 bottles
Reason for Recall
CGMP Deviations: recalling drug products following an FDA inspection.
Product Description
Finasteride Tablets USP, 5 mg, Rx Only, Packaged as: a) 30-count bottles NDC 16729-090-10 UPC 3 16729 09010 0; b) 90-count bottles NDC 16729-090-15 UPC 3 16729 09015 5; c) 100-count bottles NDC 16729-090-01 UPC 3 16729 09001 8; d) 500-count bottles NDC 16729-090-16 UPC 3 16729 09016 2; Manufactured for: Accord Healthcare, Inc., Durham, NC 27703. Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213 INDIA
Distribution Pattern
United States including Puerto Rico and Canada
Other Recalls by Accord Healthcare, Inc.
- Class II: Risk 09/16/2025
- Class II: Risk 06/20/2025
- Class II: Risk 06/20/2025
- Class II: Risk 06/20/2025
- Class II: Risk 06/20/2025
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.